Comparing the outcomes of open, laparoscopic and robot‐assisted partial nephrectomy: a network meta‐analysis

Author:

Calpin Gavin G.1ORCID,Ryan Fintan R.1,McHugh Fiachra T.2,McGuire Barry B.1

Affiliation:

1. Department of Urology St. Vincent's University Hospital Dublin 4 Ireland

2. Royal College of Surgeons in Ireland Dublin 2 Ireland

Abstract

ObjectiveTo perform a systematic review and network meta‐analysis (NMA) to determine the advantages and disadvantages of open (OPN), laparoscopic (LPN), and robot‐assisted partial nephrectomy (RAPN) with particular attention to intraoperative, immediate postoperative, as well as longer‐term functional and oncological outcomes.MethodsA systematic review was performed as per the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses‐NMA guidelines. Binary data were compared using odds ratios (ORs). Mean differences (MDs) were used for continuous variables. ORs and MDs were extracted from the articles to compare the efficacy of the various surgical approaches. Statistical validity is guaranteed when the 95% credible interval does not include 1.ResultsIn total, there were 31 studies included in the NMA with a combined 7869 patients. Of these, 33.7% (2651/7869) underwent OPN, 20.8% (1636/7869) LPN, and 45.5% (3582/7689) RAPN. There was no difference for either LPN or RAPN as compared to OPN in ischaemia time, intraoperative complications, positive surgical margins, operative time or trifecta rate. The estimated blood loss (EBL), postoperative complications and length of stay were all significantly reduced in RAPN when compared with OPN. The outcomes of RAPN and LPN were largely similar except the significantly reduced EBL in RAPN.ConclusionThis systematic review and NMA suggests that RAPN is the preferable operative approach for patients undergoing surgery for lower‐staged RCC.

Publisher

Wiley

Subject

Urology

Reference73 articles.

1. Epidemiology of Renal Cell Carcinoma

2. Incidence and Distribution of New Renal Cell Carcinoma Cases: 27-Year Trends from a Statewide Cancer Registry

3. Renal cell carcinoma in Ireland: rising mortality and survival

4. Epidemiology and diagnostic assessment of small renal masses;Ziegelmüller BK;Urologe A,2018

5. EAU Guidelines.Edn presented at the EAU Annual Congress Amsterdam 2022: EAU Guidelines Office Arnhem The Netherlands;2022. Available at:https://uroweb.org/guidelines/renal-cell-carcinoma/. Accessed November 2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3